NASDAQ$ALGN
Align Technology Inc · Q2 2024 earnings
Q2 2024 earnings · · Investor relations
Briefing
Align Technology's Q2 2024 financial results were announced, with total revenues of $1,028.5 million and diluted net income per share of $1.28, or $2.41 on a non-GAAP diluted basis.
Align Technology reported Q2 2024 total revenues of $1,028.5 million, a 2.6% increase year-over-year. Clear Aligner revenues were $831.7 million, while Imaging Systems and CAD/CAM Services revenues reached $196.8 million. The company's diluted net income per share was $1.28, or $2.41 on a non-GAAP diluted basis.
- Total Invisalign patients surpassed 18 million globally, including over 5 million teens and kids.
- Q2'24 total revenues of $1,028.5 million, increased 3.1% sequentially, and increased 2.6% year-over-year, and Q2'24 diluted net income per share was $1.28, or $2.41 on a non-GAAP diluted basis.
- Q2'24 Imaging Systems and CAD/CAM Services revenues of $196.8 million, increased 9.2% sequentially, and increased 16.1% year-over-year.
- Q2'24 Clear Aligner revenues of $831.7 million, increased 1.8% sequentially, and decreased 0.1% year-over-year.
Headline financials
Revenue & EPS history
Align · Revenue · Quarterly
$1.03B
Revenue by segment
Align · $960M total across 2 segments · Q3 2023
- Clear Aligner$795M—82.8%
- Imaging Systems and CAD/CAM Services$165M+5.0%17.2%
Forward guidance
For Q3’24, Align expects worldwide revenues to be in the range of $980M to $1,000M. For fiscal 2024, Align expects total revenue growth to be up 4% to 6% year-over-year.
Headwinds
- We expect Clear Aligner volume to be down sequentially as a result of Q3 seasonality, and Clear Aligner ASPs to be down sequentially, primarily due to foreign exchange and product mix
- We also expect Systems and Services revenues to be down sequentially because of Q3 seasonality
- We expect our Q3’24 GAAP operating margin to be below Q3’23 GAAP operating margin and Q3’24 non-GAAP operating margin to be flat to Q3’23 non-GAAP operating margin
- We expect fiscal 2024 total revenue growth to be up 4% to 6% year-over-year, due in part to lower Clear Aligner ASPs from continued unfavorable foreign exchange and product mix.
- In addition, our revised revenue outlook reflects our anticipated commercial launch of the iTero™ Lumina with restorative capabilities to occur in Q1’25, instead of 2024 as previously anticipated
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q2 2024
+2.5%
Avg return
Earnings day
+2.0%
Avg return
5 days after
+2.3%
Avg return
30 days after
66%
45 / 68 earnings
Positive
+35.5%
Q3 2020
Best reaction
-28.2%
Q3 2023
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -1.5% | -5.4% | -2.0% | |
| Q4 2025 | +8.9% | +21.7% | +7.9% | |
| Q3 2025 | +5.0% | +2.9% | +11.6% | |
| Q1 2025 | +2.0% | -0.1% | +4.4% | |
| Q4 2024 | +0.9% | -2.7% | -19.7% | |
| Q3 2024 | +2.7% | +2.4% | +7.2% | |
| Q2 2024 | -9.8% | -10.6% | -6.7% | |
| Q1 2024 | -0.4% | -2.3% | -18.0% | |
| Q4 2023 | +3.3% | +4.1% | +13.3% | |
| Q3 2023 | -28.2% | -29.7% | -17.3% | |
| Q2 2023 | +16.0% | +13.8% | +7.3% | |
| Q1 2023 | -9.6% | -9.7% | -18.8% | |
| Q4 2022 | +33.4% | +27.0% | +24.0% | |
| Q3 2022 | -16.7% | -10.9% | -10.7% | |
| Q2 2022 | +12.1% | +12.3% | +0.2% | |
| Q1 2022 | -15.7% | -14.5% | -21.2% | |
| Q4 2021 | -1.0% | -1.6% | -8.7% | |
| Q3 2021 | +6.5% | +11.5% | +6.9% | |
| Q2 2021 | +8.2% | +11.9% | +12.2% | |
| Q1 2021 | -2.8% | -3.5% | -5.1% | |
| Q4 2020 | +10.3% | +8.0% | -3.8% | |
| Q3 2020 | +35.5% | +35.8% | +33.4% | |
| Q2 2020 | -5.2% | -2.1% | -6.7% | |
| Q1 2020 | +5.6% | +3.3% | +20.7% | |
| Q4 2019 | -1.8% | -5.5% | -18.5% | |
| Q3 2019 | +16.8% | +17.2% | +28.5% | |
| Q2 2019 | -26.4% | -28.2% | -35.9% | |
| Q1 2019 | +0.2% | +7.2% | +5.2% | |
| Q4 2018 | +5.1% | +10.2% | +16.9% | |
| Q3 2018 | -25.5% | -30.1% | -29.8% | |
| Q2 2018 | -2.6% | -6.4% | -1.3% | |
| Q1 2018 | +8.4% | +4.3% | +32.9% | |
| Q4 2017 | -5.3% | -7.0% | -11.3% | |
| Q3 2017 | +16.9% | +18.5% | +26.3% | |
| Q2 2017 | +9.1% | +6.8% | +8.7% | |
| Q1 2017 | +12.4% | +12.0% | +18.7% | |
| Q4 2016 | +8.1% | +6.5% | +15.7% | |
| Q3 2016 | +3.6% | +6.8% | +14.5% | |
| Q2 2016 | +4.7% | +6.1% | +8.8% | |
| Q1 2016 | -3.5% | — | — | |
| Q4 2015 | +7.7% | — | — | |
| Q3 2015 | +10.4% | — | — | |
| Q2 2015 | -7.4% | — | — | |
| Q1 2015 | +5.8% | — | — | |
| Q4 2014 | -9.4% | — | — | |
| Q3 2014 | +7.3% | — | — | |
| Q2 2014 | +6.1% | — | — | |
| Q1 2014 | -2.4% | — | — | |
| Q4 2013 | +2.9% | — | — | |
| Q3 2013 | +32.6% | — | — | |
| Q2 2013 | +10.4% | — | — | |
| Q1 2013 | +2.3% | — | — | |
| Q4 2012 | +9.0% | — | — | |
| Q3 2012 | -26.4% | — | — | |
| Q2 2012 | +10.8% | — | — | |
| Q1 2012 | +13.7% | — | — | |
| Q4 2011 | -2.1% | — | — | |
| Q3 2011 | +2.9% | — | — | |
| Q2 2011 | -4.3% | — | — | |
| Q1 2010 | -2.0% | — | — | |
| Q1 2011 | +1.6% | — | — | |
| Q4 2010 | +5.1% | — | — | |
| Q4 2008 | +5.1% | — | — | |
| Q3 2009 | +6.3% | — | — | |
| Q3 2010 | +6.3% | — | — | |
| Q4 2009 | +0.4% | — | — | |
| Q2 2010 | +0.4% | — | — | |
| Q2 2009 | +0.4% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro